Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

SUCZYME

Financiado

VALORISATION AND OPTIMIZATION OF NOVEL FIRST-IN CLASS SUCCINATE-DEPLETING THERAP...

VALORISATION AND OPTIMIZATION OF NOVEL FIRST-IN CLASS SUCCINATE-DEPLETING THERAPIES SUCCIPRO is a spin-off company from Pere Virgili Health Institute and Rovira Virgili University. It is an early-stage drug development company focused on therapies able to modulate the succinate-SUCNR1 pathway, which have strong... ver más

31/01/2024

SUCCIPRO SL

75K€

Presupuesto del proyecto: 75K€

Líder del proyecto

SUCCIPRO SL Otra investigación y desarrollo experimental en ciencias naturales y técnicas sociedad limitada

TRL 4-5 | 50K€

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-01-31

HORIZON-EIE-2022-SCALEUP-02-02: Women TechEU ExpectedOutcome:Project results are expected to contribute to the following expected outcomes:

Innovación

Cerrada hace 2 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

SUCCIPRO SL

75.00K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

CTQ2011-29549-C02-01 CICLITOLES COMO MIMETICOS DE CARBOHIDRATOS Y SUS EFECTOS EN... 175K€ Cerrado

PDC2022-133164-I00 DESARROLLO DE UN NUEVO PRODUCTO BIOFARMACEUTICO PARA EL TRAT... 150K€ Cerrado

SAF2013-44021-R CHAPERONAS, INHIBIDORES Y NUTRACEUTICOS BASADOS EN CARBOHIDR... 218K€ Cerrado

METHYLOMIC DNA methylation markers to predict treatment success of biol... 9M€ Cerrado

METADRUG Single-Cell Metabolomics for Drug Discovery and Development 150K€ Cerrado

BES-2011-044769 PROTEOMICA, DESCUBRIMIENTO DE FARMACOS E IMAGEN DE ENZIMAS P... 43K€ Cerrado

Duración del proyecto: 7 meses Fecha Inicio: 2023-06-01
Fecha Fin: 2024-01-31

Líder del proyecto

SUCCIPRO SL Otra investigación y desarrollo experimental en ciencias naturales y técnicas sociedad limitada

TRL 4-5 | 50K€

Presupuesto del proyecto 75K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto SUCCIPRO is a spin-off company from Pere Virgili Health Institute and Rovira Virgili University. It is an early-stage drug development company focused on therapies able to modulate the succinate-SUCNR1 pathway, which have strong potential on many inflammatory and metabolic disorders. Currently, the company is developing SUCZYME, a novel first-in-class oral enzyme therapy able to deplete succinate that has Crohn's Disease as a first indication. SUCCIPRO will lead the development until the end of Clinical Phase 2a, when the asset will be licensed to a bigger pharma company. Current proposal aims to conduct critical technical and business activities with the overall goal of raising a first seed investment round. From a technological perspective, during the project the team will advance in the development of the enzyme therapy by partnering with an innovative company expert in enzyme engineering able to improve our candidates in terms of specificity, activity and stability. Later, we will conduct in vitro and in vivo efficacy studies that will enable the designation of final lead candidate. In parallel to the technical development, and in order to have more a more accurate vision about the European market, we aim to perform early price & reimbursement and market studies in Europe. We will also participate in the activities organised by InvestEU and the Enterprise Europe Network and we will introduce our company into the US start-up ecosystem to expand company's innovation network and look for investment in the US. Overall, the project will contribute to increase the TRL level of our asset, improve our competitiveness and visibility within the international biotech sector and support us in the raising of a seed investment round.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores